Evidence map›Paper›PMID 39945024›Full record

ArticleHaematologica2025

One CHiP to rule them all? Mechanistic insight into carfilzomib-induced lung injury with neutrophil extracellular trap formation following cellular immunotherapy.

Julia Katharina Scholz, Lena Stabel, Nora Rebecca Schwingen, Jasmin Knopf, Anna-Sophie Flatt, Tobias Bäuerle, Stefan Krause, Heidi Waibel, Moritz Leppkes, K Martin Kortüm and 5 more

Abstract read
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Julia Katharina ScholzDepartment of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF).
Lena StabelDepartment of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF).
Nora Rebecca SchwingenDepartment of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF).
Jasmin KnopfDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Department of Pediatric Surgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen.
Anna-Sophie FlattDepartment of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF).
Tobias BäuerleDepartment of Diagnostic and Interventional Radiology, Universitätsmedizin Mainz.
Stefan KrauseDepartment of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF).
Heidi WaibelDepartment of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF).
Moritz LeppkesDepartment of Internal Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen.
K Martin KortümMedizinische Klinik und Poliklinik II, Uniklinikum Würzburg, Würzburg; Bayerisches Krebsforschungszentrum, partner site Würzburg.
Hermann EinseleMedizinische Klinik und Poliklinik II, Uniklinikum Würzburg, Würzburg; Bayerisches Krebsforschungszentrum, partner site Würzburg.
Andreas MackensenDepartment of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF).
Martin HerrmannDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Department of Pediatric Surgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany; Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen.
Simon VölklDepartment of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF).
Fabian MüllerDepartment of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Uniklinik Erlangen, Erlangen, Germany; Bavarian Cancer Research Center (BZKF). fabian.mueller@uk-erlangen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39945024
PMCPMC12208148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.